Differentially Methylated Regions in Pediatric Multiple Sclerosis

An observational study analyzed DNA samples from 175 subjects (122 Pediatric MS patients and 53 healthy controls) and identified 55 differentially methylated regions (DMRs), with 28 affecting promoter regions. Notably, Epstein-Barr virus (EBV) infection emerged as a significant pathway in this context.

Tags: #EBV #Epigenetics #PediatricMS #Genetics
Most relevant to: Neurologist, Immunologist
Source: Read original source (PMID 42789917)

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

These findings provide insights about potential epigenetic mechanisms and environmental interactions in the early development of pediatric multiple sclerosis, suggesting areas for further research.

What this does not prove

The study establishes only associations without confirming causation and does not clarify the specific roles of each DMR in MS pathogenesis.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Observational
Participants / samples: 175 · Total number of subjects analyzed (122 PedMS patients, 53 healthy controls)
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: 2026-09-25
Evidence reviewed: Abstract only
Regulatory approval: Not reported
Research areas: Not classified

Original sources

Primary evidenceEpigenetic Factors in Pediatric Multiple Sclerosis Linked to EBV ↗

Supporting passages (8)

study designThis study aimed to identify differentially methylated regions (DMRs) that mediate the interplay between environmental triggers and genomic factors in the early stages of the disease.

subjectsIn this multicenter study, we analyzed peripheral blood DNA from 175 Italian subjects (122 PedMS patients, 53 healthy controls) using the Infinium Methylation EPIC Array v2.

sample sizeMETHODS: In this multicenter study, we analyzed peripheral blood DNA from 175 Italian subjects (122 PedMS patients, 53 healthy controls) using the Infinium Methylation EPIC Array v2.

sample size basisMETHODS: In this multicenter study, we analyzed peripheral blood DNA from 175 Italian subjects (122 PedMS patients, 53 healthy controls) using the Infinium Methylation EPIC Array v2.

publication date2026-09-25

primary endpointThis study aimed to identify differentially methylated regions (DMRs) that mediate the interplay between environmental triggers and genomic factors in the early stages of the disease.

findingsOur analysis revealed 55 DMRs, with 28 affecting promoter regions.

limitationsTitle: Epigenetic Insights in Pediatric Multiple Sclerosis: DNA Methylation Highlights an Involvement of Epstein-Barr Virus Infection and Host Immune Networks.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.